Next Article in Journal
Distribution of Nanoparticles in a Turbulent Taylor–Couette Flow Considering Particle Coagulation and Breakage
Next Article in Special Issue
Graphite Classification Based on Improved Convolution Neural Network
Previous Article in Journal
Enhanced Cell Performance and Improved Catalyst Utilization for a Direct Methanol Fuel Cell with an In-Plane Gradient Loading Catalyst Electrode
Previous Article in Special Issue
Gas to Liquids Techno-Economics of Associated Natural Gas, Bio Gas, and Landfill Gas
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Environmental and Sustainability Analysis of a Supercritical Carbon Dioxide-Assisted Process for Pharmaceutical Applications

by
Paolo Trucillo
1,2,*,
Roberta Campardelli
1,3 and
Iolanda De Marco
1,4
1
Department of Industrial Engineering (DIIn), University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy
2
Department of Chemical, Material and Industrial Production Engineering, University of Naples Federico II, Piazzale V. Tecchio 80, 80125 Napoli, Italy
3
Department of Civil, Chemical and Environmental Engineering (DICCA), University of Genoa, Via Opera Pia 15, 16145 Genova, Italy
4
Research Centre for Biomaterials BIONAM, University of Salerno, Via Giovanni Paolo II 132, 84084 Fisciano, Italy
*
Author to whom correspondence should be addressed.
Processes 2021, 9(10), 1788; https://doi.org/10.3390/pr9101788
Submission received: 15 September 2021 / Revised: 30 September 2021 / Accepted: 5 October 2021 / Published: 8 October 2021
(This article belongs to the Special Issue Innovation in Chemical Plant Design)

Abstract

:
Drug delivery systems (DDS) are artificial devices employed to enhance drug bioavailability during administration to a human body. Among DDS, liposomes are spherical vesicles made of an aqueous core surrounded by phospholipids. Conventional production methods are characterized by several drawbacks; therefore, Supercritical assisted Liposome formation (SuperLip) has been developed to overcome these problems. Considering that the use of high pressures involves high energy cost, in this paper, sustainability indicators were calculated to quantitatively evaluate the emissions related to the attainment of liposomes containing daunorubicin (a model antibiotic drug) using the SuperLip process. The indicators were depicted using a spider diagram to raise the actual weaknesses of this technique; some variations were proposed in the process layout to solve the critical issues. According to the literature, many studies related to the pharmaceutical industry are expressed in terms of solid, liquid waste, and toxic emissions; however, liposomes have never explicitly been considered for an analysis of environmental sustainability.

1. Introduction

Drug delivery systems (DDS) are artificial devices employed to enhance drug bioavailability during topical delivery [1]. Several systems and complexes have been developed at micro and nano levels to achieve high entrapment efficiency of therapeutic agents [2], targeted delivery to specific human tissues, and improved protection of the entrapped drug from degradation phenomena [3].
Among DDS, liposomes are spherical vesicles made of an aqueous core surrounded by one or more layers of phospholipids [4], generally employed for pharmaceutical [5], cosmetic [6], and nutraceutical purposes [7]. Currently, the main liposomes producing countries are the United States of America, Republic of China, Japan, and the western countries of Europe [8], with the following market share: pharmaceutic industries (61.7%), cosmetics (22.8%), and nutraceutical industries (15.6%) [9,10,11,12].
The well-known conventional methods for liposome production are generally characterized by low entrapment efficiencies of active principles and difficult replicability of Particle Size Distribution (PSD), due to discontinuous process layouts [13]. The Supercritical assisted Liposome formation (SuperLip) technique has been recently developed to overcome these problems, consisting of the inversion of the traditional production steps of production [14] through an atomization step directly into a supercritical medium containing the phospholipids. This process has been successfully tested for the entrapment of proteins, antioxidants, dietary supplements, dyes, and antibiotics [14,15].
The SuperLip process has been developed primarily at a lab scale; however, its configuration layout is continuous, which guarantees its replicability on a larger scale [16,17]. Comparing to other processes proposed in the literature, SuperLip has several advantages, as described in the sketches reported in Figure 1, where SR represents the Solvent Residue and EE the Encapsulation Efficiency (in particular, see Figure 1b).
According to the literature published on SuperLip, it is possible to affirm that other well-known processes, such as ethanol injection [18,19,20] or reverse-phase evaporation [21,22], resulted in the production of larger liposomes (around 500 nm) and encapsulation efficiencies between 40% and 60%. In particular, the conventional Bangham method [23,24] results in vesicles’ mean dimensions highly variable, from 1 to 100 µm, and encapsulation efficiencies are generally lower than 30%. Concerning Figure 1b, the bottom of the pyramid is characterized by the worst operating conditions. These processes are characterized by low entrapment efficiencies, and amounts of solvent residues above the Food and Drug Administration (FDA) imposed limits [25]. Therefore, a high solvent residue also means that these processes create liposomes formulations with a high level of toxicity [26]. In the second level of the pyramid, semi-continuous processes and post-processing steps are reported, such as Reverse Phase Evaporation and Microfluidic channel techniques [27], that result in the production of quasi-homogeneous samples. Due to this not optimal homogeneity, vesicles mean dimensions are reduced after extrusion or sonication [28]. At the third level of this pyramid, dense gas processes find a good location, also in terms of reduced solvent residue, thanks to the use of carbon dioxide in supercritical conditions. These processes, such as Supercritical AntiSolvent (SAS) [29], Depressurization of an Expanded Solution into Aqueous Media (DESAM) [30], Depressurization of a CO2-expanded liquid organic solution (DELOS) [31], and Supercritical Reverse Phase Evaporation (SRPE) [32], were developed to avoid the high cost of post-processing steps, avoiding loss of expensive molecules. These methods were obtained after great technical efforts and encountered a success after proposal in the academic community. Some improvements were still needed to produce liposomes available to be sold in the market with a good balance among profitability, environmental impact, and energy consumption [21,33]. SuperLip process was demonstrated to provide all these advantages.
For the reasons listed above, it was considered attractive to focus on the main advantage of SuperLip: the low solvent residue, as indicated in previous work [17]. To better explain this advantage, a working map has been proposed in Figure 2, creating a strict correspondence among two important operating parameters (Gas to Liquid Ratio, i.e., feeding ratio, calculated as carbon dioxide over ethanol flow rates on a mass basis, and mean diameter of the liposomes produced). In this diagram, the surface of each circled area represents the concentration of solvent residue obtained in different operating conditions; whereas, the center of each circle is related to a specific Encapsulation Efficiency and a specific Gas To Liquid Ratio. As indicated in Figure 2, vesicles produced with the conventional technique are characterized by a high level of solvent residue (20,000 ppm), measured after evaporation; whereas, small circles are related to liposomes produced with an ethanol residue lower than 150 ppm.
After these considerations, the elimination of solvent residue becomes fundamental in pharmaceutical processes [34]; in particular, SuperLip eliminates large parts of its solvent from the top of the main process unit. The remaining amount can be eliminated using rotary evaporation performed on the recovered liquid suspension. This step can avoid the pharmaceutical formulations to be toxic for cells [18,34]. Moreover, the commercial profitability of SuperLip has been already demonstrated, in terms of economic and financial analysis [35].
Solvent residue causes a significant environmental impact during the production of drug carriers. Therefore, the most common way to calculate the environmental impact is represented by the analysis of sustainability indicators, or the Life Cycle Assessment, largely used in many fields, such as energy [36], beverages and foods [37,38,39,40,41], pharmaceutical delivery [42,43,44] systems, cosmetics [45], and wastewater treatments [46]. Concerning pharmaceutical industry, a few papers [43,47,48,49] are related to the management of solid waste and solvent treatment; moreover, liposomes have never been considered for a sustainability evaluation.
Therefore, the aim of this work is the assessment of the environmental impact of the SuperLip process. The eco-balance of this technique will be evaluated to study the effects of liposomes production using this supercritical assisted technique, from the acquiring of raw materials and reagents to the manufacture of the final produced vesicles. An inventory of materials employed in this process and energy consumption will be provided, evaluating the inputs and the outputs of the process, and making a final analysis on the results, according to market profitability reference. A model drug such as daunorubicin, which is generally employed against leukemia [50], will be considered for this analysis. The results of this study will also improve the proposed technique and certify its quality, with the final aim to assess the profitability of a scale-up for this process, to achieve high volumes of commercialization of this liposome-based products.

2. Process Description

2.1. Apparatus

SuperLip process consists of three feeding lines: carbon dioxide is pumped at the flow rate of 6.5 g/min using an Ecoflow pump (mod LDC-M-2, Lewa, Germany), until reaching the pressure of 100 bar; an ethanol/phospholipids solution is fed at the flow rate of 3.5 mL/min, using a high-pressure precision pump (Model 305, Gilson, France). Ethanol and carbon dioxide are first mixed and then heated up to 40 °C, using thin Band Heaters (3 × 120 W, Watlow Italy, Milano, Italy). The carbon dioxide over ethanol feeding ratio is called Gas to Liquid Ratio of the Expanded Liquid (GLR-EL), and it has been set at 2.4. The ethanol + lipids + carbon dioxide mixture is sent to a stainless-steel vessel (500 cm3) that works at the pressure of 100 bar and temperature of 40 °C, heated using Band Heaters (2 × 400 W, Watlow Italy, Milan, Italy).
A third feeding line sends water (plus a dissolved hydrophilic drug) to the system; another high-pressure precision pump supports this feeding line at the flow rate of 10 mL/min (Model 305, Gilson, France). The water flow rate is atomized in droplets in the formation vessel, using an 80 µm nozzle.
The production of liposomes occurs in the vessel of SuperLip, by first creating water droplets and then the lipid layer around. Liposomes are collected from the bottom of the vessel using an on/off valve. The separation of the ethanol/carbon dioxide expanded liquid occurs from the top of the vessel, where an exit line has been designed. This line is heated at 30 °C using a tubular resistance (275 W, Watlow Italy, Milan, Italy). A stainless-steel separator (300 cm3) is employed to separate ethanol and carbon dioxide at the pressure of 10 bar. A rotameter (mod. N.5–2500, Serval 115022, ASA, Italy) is used to measure carbon dioxide flow rate.
Liposomes are produced from SuperLip in aqueous suspension. However, a reduced amount of ethanol is still present in the final solution; therefore, liposomes suspensions are sent to rotary evaporation, operating at 30 °C under vacuum at a stirring rate of 120 rpm (for 30 min), in order to eliminate solvent residue without damaging vesicles produced.

2.2. Materials and Procedures

The raw materials for the production of liposomes production are essentially phospholipids, that are provided by several companies such as Sigma Aldrich (Milan, Italy) or Lipoid (Ludwigshafen, Germany). Daunorubicin has been purchased from Sigma Aldrich, Milan, Italy; whereas, distilled water was self-produced using a lab-scale distillation column, separated from the SuperLip plant. Carbon dioxide is provided by Morlando Group, Naples, Italy, and it is stocked into an external tank with a volume of 800 L. The carbon dioxide needs to be cooled using a cooling bath at the temperature of −10 °C; once that carbon dioxide is in liquid state, it is pumped to the system, where it is again heated up to 40 °C. The pumps guarantee the pressure of 100 bar constant to achieve supercritical conditions for carbon dioxide. Ethanol and water are pumped into the system as well. The heart of the production is characterized by ethanol and carbon dioxide pre-mixing and heating, followed by the mixture in the formation vessel, together with the atomized droplets of water + drug. The final product is the liposomes suspension, which is subjected to solvent elimination post-treatment. Ethanol and carbon dioxide are separated from the formation vessel and sent to depressurization and splitting. In Table 1, the process details and main activities are described.

3. Methodology

As indicated in similar studies [51], this work aims to evaluate the emissions related to the use of the SuperLip technique to produce a liposomal formulation containing an active principle (daunorubicin). The system boundaries are characterized by the operating parameters described in this section and are highlighted in Figure 3. Equipment impacts were not included.
An indicator is an index used to define the sustainability conditions of a working process, giving a practical sense and perception of the system. It generally does not work as a preliminary index, but it contains information about an already developed phenomenon or process. It is a way to give a precise meaning to the raw data of the process.
Due to the large number of collected values related to a process plant and several existing indexes, the application of this methodology to different processes could be difficult. For this reason, a sustainability scale can be defined by enclosing two scenarios representing the best case (100% sustainable process) and the worst case (0% sustainable). The final score related to each indicator is represented by a combination of worst, best case, and actual value, i.e., the real value of the parameters measured in the process. The general formula is the following:
Percent   Score   =   Actual     Worst Best     Worst × 100 %
Sustainability indicators were studied according to the calculation of the following percent scores [52,53] defined in Table 2.

4. Results and Discussion

The sustainability indicators, whose formulas were reported in the Methods Section, were calculated taking into account the actual values of SuperLip working conditions, considering the best and worst values indicated for each specific situation. Environmental and economic indicators such as Global Warming Potential and Global Warming Intensity were considered. These two indicators need to be shown together; indeed, the first one correlates the emissions of carbon dioxide (on mass basis) to the mass of product obtained. The second one correlates the emissions of carbon dioxide to the economic value of the products sold. In other words, these two indicators compare the environmental impact and the profitability of the process, in order to understand if the process is lacking in both areas, or lacking in just one of the two. This comparison has the potential to indicate the points of strength of the process and the main weaknesses.
More indicators about energy consumption were also evaluated, providing correlations among power consumption and the mass of products or the sales revenue generated by those products. Another environmental indicator was determined by liquid waste volume and recycled material fraction. The system’s productivity was also evaluated in terms of reaction efficiency, i.e., the transformation of raw materials into products through the process. Total mass consumption was put in correlation with the mass of product and also to the sales revenue. Actual values shown in Table 3 represent the real situation of SuperLip working in standard conditions.
Actual values were inserted in the score calculation formula, and the scores for each indicator were obtained in terms of percentage (see Table 4 under the column “before optimization”). In this context, 0% represents “totally not sustainable” and 100% “totally sustainable”.
To achieve better control of parameters and increase the previously calculated scores, some modifications could be proposed to the layout of the process. In particular, energy does not require specific intervention. Therefore, no problems were registered in terms of the operating cost of the process.
The weakest points of the process SuperLip emerged as the feeding of CO2, ethanol, and water. To improve these pumping steps and increase the related sustainability scores, 90% recirculation of ethanol has been proposed via rotary evaporation followed by condensation. The additional instrument energy required is negligible, according to the volumes of production. In this manner, the specific liquid waste volume will be 10% of the previously calculated one.
Another possible modification is the 90% recirculation of carbon dioxide employed in the process. In this manner, global warming potential will be calculated considering only 10% of the carbon dioxide releasing mass.
Consequently, reaction mass efficiency will be positively increased to 85%, and recycled material fraction will become the sum of 90% of ethanol recirculated plus 90% of recirculated carbon dioxide. Moreover, a 50% water recirculation has been proposed to the process after recovering the processing water. The effect of these new calculations and process layout brought to the definition of a new scenario, as expressed in Table 4.
The sustainability analysis calculated and reported in Table 4 was translated into a spider diagram (shown in Figure 4), i.e., a visual tool used to organize scores and compare them logically and quickly.
In this diagram, the blue line represents the previous situation, while the orange line is related to the case in the new process configuration; it is possible to say that sustainability indicators significantly increased after process modification (see Figure 4 and Table 4).
According to results shown in Table 4, the differentiation among Global Warming potential and Global Warming Intensity results to be particularly important. Sustainability analysis generally embraces all three spheres of a process: environmental impact, economic convenience, and social impact. In this case, GWP and GWI represent the intersection between environment and economic impacts. In fact, after a careful analysis of this process, it appears very clear that the GWP, that is the environmental impact related to the product mass, has a score of only 57%; on the other hand, the GWI, that is the environmental impact correlated to the sales of the product, has a top score of 100%. In other words, the economic value of SuperLip products is so high that almost justifies the process carbon dioxide emissions; however, the other indicator shows that the environmental impact is not negligible. Therefore, the idea of modifying the process layout adding a recirculation step, resolves the environmental problem while maintaining a high economic value of the products.
This positive effect was also registered, after the introduction for recirculation, in terms of liquid waste and the fraction of water consumed in the process. The overall variation of the SuperLip layout resulted in an overall increase in the efficiency of the process.

5. Conclusions

In this work, we started by analyzing a process employed to produce drug carriers at high working pressures. After establishing the process economic profitability, we realized that further analysis on sustainability was needed. Considering the concept of sustainable development, we studied the possibility of using resources without compromising their future availability; in our case, this resulted in a proper recirculation of the process input materials.
The SuperLip process was studied in terms of power consumption, sales revenue, and global warming to balance them simultaneously. The key points were characterized by waste management in terms of recycling, and energy recovery through process efficiency enhancement, reducing the impact of CO2 emissions on the mass of products obtained from the process. Process indicators were calculated and analyzed in the SuperLip working process, from cradle to grave, not just considering it as a black box.
After proposing recirculation, several indicators improved significantly, such as global warming potential, from 57% to 96%; specific liquid waste volume, from 74% to 97%; reaction mass efficiency, from 73% to 85%; fractional water consumption, from 66% to 83%, and recycled material fraction, from 0% to 45%. The analysis resulted in being successful in demonstrating the sustainability potential of the SuperLip process. Further studies will regard the possibility of scaling up this analysis to other industrial processes to produce polymeric drug carriers.

Author Contributions

Conceptualization, P.T., R.C. and I.D.M.; methodology, P.T., R.C. and I.D.M.; validation, R.C. and I.D.M.; formal analysis, P.T.; data curation, P.T.; writing—original draft preparation, P.T.; writing—review and editing, R.C. and I.D.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Tiwari, G.; Tiwari, R.; Sriwastawa, B.; Bhati, L.; Pandey, S.; Pandey, P.; Bannerjee, S.K. Drug delivery systems: An updated review. Int. J. Pharm. Investig. 2012, 2, 2. [Google Scholar]
  2. Patra, J.K.; Das, G.; Fraceto, L.F.; Campos, E.V.R.; del Pilar Rodriguez-Torres, M.; Acosta-Torres, L.S.; Diaz-Torres, L.A.; Grillo, R.; Swamy, M.K.; Sharma, S. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018, 16, 71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Ito, Y. Drug delivery systems. In Photochemistry for Biomedical Applications; Springer: Berlin/Heidelberg, Germany, 2018; pp. 231–275. [Google Scholar]
  4. Pattni, B.S.; Chupin, V.V.; Torchilin, V.P. New developments in liposomal drug delivery. Chem. Rev. 2015, 115, 10938–10966. [Google Scholar] [CrossRef] [PubMed]
  5. Ozer, A.Y. Alternative applications for drug delivery: Nasal and pulmonary routes. In Nanomaterials and Nanosystems for Biomedical Applications; Springer: Berlin/Heidelberg, Germany, 2007; pp. 99–112. [Google Scholar]
  6. Van Tran, V.; Moon, J.-Y.; Lee, Y.-C. Liposomes for delivery of antioxidants in cosmeceuticals: Challenges and development strategies. J. Control. Release 2019, 300, 114–140. [Google Scholar] [CrossRef] [PubMed]
  7. Taylor, T.M.; Weiss, J.; Davidson, P.M.; Bruce, B.D. Liposomal nanocapsules in food science and agriculture. Crit. Rev. Food Sci. Nutr. 2005, 45, 587–605. [Google Scholar] [CrossRef]
  8. Zhou, X.; Zhao, G. Global liposome research in the period of 1995–2014: A bibliometric analysis. Scientometrics 2015, 105, 231–248. [Google Scholar] [CrossRef]
  9. Radhika, P.R.; Singh, R.B.M.; Sivakumar, T. Nutraceuticals: An area of tremendous scope. Int. J. Res. 2011, 2, 410–415. [Google Scholar]
  10. Aditya, N.; Espinosa, Y.G.; Norton, I.T. Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application. Biotechnol. Adv. 2017, 35, 450–457. [Google Scholar] [CrossRef] [Green Version]
  11. Crommelin, D.J.; Storm, G. Liposomes: From the bench to the bed. J. Liposome Res. 2003, 13, 33–36. [Google Scholar] [CrossRef]
  12. Singh, H.; Thompson, A.; Liu, W.; Corredig, M. Liposomes as food ingredients and nutraceutical delivery systems. In Encapsulation Technologies and Delivery Systems for Food Ingredients and Nutraceuticals; Elsevier: Amsterdam, The Netherlands, 2012; pp. 287–318. [Google Scholar]
  13. Mozafari, M.R. Liposomes: An overview of manufacturing techniques. Cell. Mol. Biol. Lett. 2005, 10, 711. [Google Scholar]
  14. Trucillo, P.; Campardelli, R.; Reverchon, E. Supercritical CO2 assisted liposomes formation: Optimization of the lipidic layer for an efficient hydrophilic drug loading. J. CO2 Util. 2017, 18, 181–188. [Google Scholar] [CrossRef]
  15. Trucillo, P.; Campardelli, R.; Aliakbarian, B.; Perego, P.; Reverchon, E. Supercritical assisted process for the encapsulation of olive pomace extract into liposomes. J. Supercrit. Fluids 2018, 135, 152–159. [Google Scholar] [CrossRef]
  16. Trucillo, P.; Campardelli, R.; Reverchon, E. A versatile supercritical assisted process for the one-shot production of liposomes. J. Supercrit. Fluids 2019, 146, 136–143. [Google Scholar] [CrossRef]
  17. Trucillo, P.; Campardelli, R.; Scognamiglio, M.; Reverchon, E. Control of liposomes diameter at micrometric and nanometric level using a supercritical assisted technique. J. 2 Util. 2019, 32, 119–127. [Google Scholar] [CrossRef]
  18. Dua, J.; Rana, A.; Bhandari, A. Liposome: Methods of preparation and applications. Int. J. Pharm. Stud. Res. 2012, 3, 14–20. [Google Scholar]
  19. Pons, M.; Foradada, M.; Estelrich, J. Liposomes obtained by the ethanol injection method. Int. J. Pharm. 1993, 95, 51–56. [Google Scholar] [CrossRef]
  20. Laouini, A.; Jaafar-Maalej, C.; Limayem-Blouza, I.; Sfar, S.; Charcosset, C.; Fessi, H. Preparation, characterization and applications of liposomes: State of the art. J. Colloid Sci. Biotechnol. 2012, 1, 147–168. [Google Scholar] [CrossRef]
  21. Meure, L.A.; Foster, N.R.; Dehghani, F. Conventional and dense gas techniques for the production of liposomes: A review. AAPS PharmSciTech 2008, 9, 798. [Google Scholar] [CrossRef] [Green Version]
  22. Otake, K.; Shimomura, T.; Goto, T.; Imura, T.; Furuya, T.; Yoda, S.; Takebayashi, Y.; Sakai, H.; Abe, M. Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 2006, 22, 2543–2550. [Google Scholar] [CrossRef]
  23. Deamer, D.W. From “banghasomes” to liposomes: A memoir of Alec Bangham, 1921–2010. FASEB J. 2010, 24, 1308–1310. [Google Scholar] [CrossRef]
  24. Liu, W.; Ye, A.; Liu, W.; Liu, C.; Singh, H. Stability during in vitro digestion of lactoferrin-loaded liposomes prepared from milk fat globule membrane-derived phospholipids. J. Dairy Sci. 2013, 96, 2061–2070. [Google Scholar] [CrossRef] [Green Version]
  25. He, T.; Liang, Q.; Wang, J.; Luo, G. Microfluidic Fabrication of Liposomes as Drug Carriers. Prog. Chem. 2018, 30, 1734–1748. [Google Scholar]
  26. Grimaldi, N.; Andrade, F.; Segovia, N.; Ferrer-Tasies, L.; Sala, S.; Veciana, J.; Ventosa, N. Lipid-based nanovesicles for nanomedicine. Chem. Soc. Rev. 2016, 45, 6520–6545. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mufamadi, M.S.; Pillay, V.; Choonara, Y.E.; Du Toit, L.C.; Modi, G.; Naidoo, D.; Ndesendo, V.M. A review on composite liposomal technologies for specialized drug delivery. J. Drug Deliv. 2011, 1–19. [Google Scholar] [CrossRef] [PubMed]
  28. Pradhan, P.; Guan, J.; Lu, D.; Wang, P.G.; Lee, L.J.; Lee, R.J. A facile microfluidic method for production of liposomes. Anticancer Res. 2008, 28, 943–947. [Google Scholar]
  29. William, B.; Noémie, P.; Brigitte, E.; Géraldine, P. Supercritical fluid methods: An alternative to conventional methods to prepare liposomes. Chem. Eng. J. 2020, 383, 123106. [Google Scholar] [CrossRef]
  30. Meure, L.A.; Knott, R.; Foster, N.R.; Dehghani, F. The depressurization of an expanded solution into aqueous media for the bulk production of liposomes. Langmuir 2009, 25, 326–337. [Google Scholar] [CrossRef]
  31. Zhao, L.; Temelli, F. Preparation of liposomes using a modified supercritical process via depressurization of liquid phase. J. Supercrit. Fluids 2015, 100, 110–120. [Google Scholar] [CrossRef]
  32. Huang, Z.; Li, X.; Zhang, T.; Song, Y.; She, Z.; Li, J.; Deng, Y. Progress involving new techniques for liposome preparation. Asian J. Pharm. Sci. 2014, 9, 176–182. [Google Scholar] [CrossRef] [Green Version]
  33. Beh, C.C.; Mammucari, R.; Foster, N.R. Lipids-based drug carrier systems by dense gas technology: A review. Chem. Eng. J. 2012, 188, 1–14. [Google Scholar] [CrossRef]
  34. Cortesi, R.; Esposito, E.; Gambarin, S.; Telloli, P.; Menegatti, E.; Nastruzzi, C. Preparation of liposomes by reverse-phase evaporation using alternative organic solvents. J. Microencapsul. 1999, 16, 251–256. [Google Scholar] [CrossRef]
  35. Trucillo, P.; Campardelli, R.; Iuorio, S.; De Stefanis, P.; Reverchon, E. Economic analysis of a new business for liposome manufacturing using a high-pressure system. Processes 2020, 8, 1604. [Google Scholar] [CrossRef]
  36. González-García, S.; Dias, A.C.; Clermidy, S.; Benoist, A.; Bellon Maurel, V.; Gasol, C.M.; Gabarrell, X.; Arroja, L. Comparative environmental and energy profiles of potential bioenergy production chains in Southern Europe. J. Clean. Prod. 2014, 76, 42–54. [Google Scholar] [CrossRef]
  37. De Marco, I.; Riemma, S.; Iannone, R. Life cycle assessment of supercritical CO2 extraction of caffeine from coffee beans. J. Supercrit. Fluids 2018, 133, 393–400. [Google Scholar] [CrossRef]
  38. Berlin, J. Environmental life cycle assessment (LCA) of Swedish semi-hard cheese. Int. Dairy J. 2002, 12, 939–953. [Google Scholar] [CrossRef]
  39. Biswas, W.K.; Naude, G. A life cycle assessment of processed meat products supplied to Barrow Island: A Western Australian case study. J. Food Eng. 2016, 180, 48–59. [Google Scholar] [CrossRef]
  40. De Marco, I.; Riemma, S.; Iannone, R. Uncertainty of input parameters and sensitivity analysis in life cycle assessment: An Italian processed tomato product. J. Clean. Prod. 2018, 177, 315–325. [Google Scholar] [CrossRef]
  41. Gazulla, C.; Raugei, M.; Fullana-I-Palmer, P. Taking a life cycle look at crianza wine production in Spain: Where are the bottlenecks? Int. J. Life Cycle Assess. 2010, 15, 330–337. [Google Scholar] [CrossRef]
  42. De Marco, I.; Riemma, S.; Iannone, R. Life cycle assessment of supercritical impregnation: Starch aerogel + a-tocopherol tablets. J. Supercrit. Fluids 2019, 143, 305–312. [Google Scholar] [CrossRef]
  43. Emara, Y.; Lehmann, A.; Siegert, M.W.; Finkbeiner, M. Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review. Integr. Environ. Assess. Manag. 2019, 15, 6–18. [Google Scholar] [CrossRef] [Green Version]
  44. Wernet, G.; Conradt, S.; Isenring, H.P.; Jiménez-González, C.; Hungerbühler, K. Life cycle assessment of fine chemical production: A case study of pharmaceutical synthesis. Int. J. Life Cycle Assess. 2010, 15, 294–303. [Google Scholar] [CrossRef]
  45. Guilbot, J.; Kerverdo, S.; Milius, A.; Pomrehn, F. Life cycle assessment of surfactants: The case of an alkyl polyglucoside used as a self emulsifier in cosmetics. Green Chem. 2013, 15, 3337–3354. [Google Scholar] [CrossRef]
  46. Lassaux, S.; Renzoni, R.; Germain, A. Life cycle assessment of water from the pumping station to the wastewater treatment plant. Int. J. Life Cycle Assess. 2007, 12, 118–126. [Google Scholar]
  47. Mata, T.M.; Martins, A.A.; Neto, B.; Martins, M.L.; Salcedo, R.L.R.; Costa, C.A.V. Lca tool for sustainability evaluations in the pharmaceutical industry. Chem. Eng. Trans. 2012, 26, 261–266. [Google Scholar]
  48. Emara, Y.; Siegert, M.-W.; Lehmann, A.; Finkbeiner, M. Life cycle management in the pharmaceutical industry using an applicable and robust LCA-based environmental sustainability assessment approach. In Designing Sustainable Technologies, Products and Policies; Springer: Cham, Switzerland; Berlin/Heidelberg, Germany, 2018; pp. 79–88. [Google Scholar]
  49. Raymond, M.J.; Slater, C.S.; Savelski, M.J. LCA approach to the analysis of solvent waste issues in the pharmaceutical industry. Green Chem. 2010, 12, 1826–1834. [Google Scholar] [CrossRef]
  50. Zhang, Y.; Zhai, M.; Chen, Z.; Han, X.; Yu, F.; Li, Z.; Xie, X.; Han, C.; Yu, L.; Yang, Y. Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma. Drug Deliv. 2017, 24, 1045–1055. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Goedkoop, M.; Heijungs, R.; Huijbregts, M.; De Schryver, A.; Struijs, J.; van Zelm, R. ReCiPe 2008, A Life Cycle Impact Assessment Method Which Comprises Harmonised Category Indicators at the Midpoint and the Endpoint Level. First Edition. Report I: Characterization. 2009. Available online: http://www.lcia-recipe.net (accessed on 10 September 2021).
  52. Ruiz-Mercado, G.J.; Smith, R.L.; Gonzalez, M.A. Sustainability indicators for chemical processes: I. Taxonomy. Ind. Eng. Chem. Res. 2012, 51, 2309–2328. [Google Scholar] [CrossRef]
  53. Ruiz-Mercado, G.J.; Smith, R.L.; Gonzalez, M.A. Sustainability indicators for chemical processes: II. Data needs. Ind. Eng. Chem. Res. 2012, 51, 2329–2353. [Google Scholar] [CrossRef]
  54. GlaxoSmithKline plc. Annual Report 2019. Available online: www.gsk.com/annualreport (accessed on 1 September 2021).
  55. Air Products. 2010 Sustainability Report. Available online: http://www.airproducts.com/responsibility/2010AnnualReport.htm (accessed on 1 September 2021).
  56. Constable, D.J.; Curzons, A.D.; Cunningham, V.L. Metrics to ‘green’chemistry—Which are the best? Green Chem. 2002, 4, 521–527. [Google Scholar] [CrossRef]
  57. ICIS Chemical Business. ICIS Pricing Glycerine Report. Available online: http://www.icispricing.com/il_shared/Samples/SubPage170.asp (accessed on 1 September 2021).
  58. Sustainability Reporting 2009. Available online: http://www.bp.com/subsection.do?categoryID=9032624&contentID=7061085 (accessed on 1 September 2021).
Figure 1. (a) A features map of encapsulation efficiencies and mean size of liposomes produced using different techniques. (b) Pyramid sketch of the main advantages and disadvantages of liposomes production (SR: Solvent Residue, EE: Encapsulation Efficiency).
Figure 1. (a) A features map of encapsulation efficiencies and mean size of liposomes produced using different techniques. (b) Pyramid sketch of the main advantages and disadvantages of liposomes production (SR: Solvent Residue, EE: Encapsulation Efficiency).
Processes 09 01788 g001
Figure 2. Bubble diagrams: comparison of solvent residue amount among SuperLip process (small circles) and conventional method (large circle). The surface of circles express the concentration of ethanol in ppm, in the final aqueous suspension.
Figure 2. Bubble diagrams: comparison of solvent residue amount among SuperLip process (small circles) and conventional method (large circle). The surface of circles express the concentration of ethanol in ppm, in the final aqueous suspension.
Processes 09 01788 g002
Figure 3. SuperLip system boundaries.
Figure 3. SuperLip system boundaries.
Processes 09 01788 g003
Figure 4. Spider diagram representing the sustainability analysis of the SuperLip process before (blue) and after (orange) optimization.
Figure 4. Spider diagram representing the sustainability analysis of the SuperLip process before (blue) and after (orange) optimization.
Processes 09 01788 g004
Table 1. Process details and assumptions.
Table 1. Process details and assumptions.
ProcessCharacteristics and Details
Energy supply to facilityItalian energy mix medium voltage
Production
Pressurizationt1 = 0.25 h; carbon dioxide and ethanol supply; energy supply
Operating conditions stabilizationT = 40 °C; P = 100 bar; t2 = 0.2 h;
carbon dioxide and ethanol supply; energy supply
InjectionT = 40 °C; P = 100 bar; t3 = 1 h; carbon dioxide and ethanol supply; water solution; energy supply
SeparationT = 30 °C; P = 10 bar; t4 = 1 h
StockingT = 4 °C; P = 1 bar; t5 = 0.5 h
Carbon dioxide supply to facilityTransport by truck, 28 t from Sant’Antimo (Italy) To the University of Salerno (Italy), distance = 67 km
Reagents supply to facilityTransport by truck, 28 t from Milan to the University of Salerno (Italy), distance = 800 km
Table 2. Sustainability indicators calculation formula.
Table 2. Sustainability indicators calculation formula.
FormulaBestWorst
Global   warming   potential   =   Total   mass   of   CO 2   released Mass   of   product No CO2 releasedAll CO2 released
Global   warming   intensity   =   Total   mass   of   CO 2   released Sales   revenue No CO2 releasedAll CO2 released
Specific   energy   intensity   =   Total   energy   of   the   process Mass   of   product Min. theoretical energy (Gibbs)5.85 × 1011 KJ/Kg [54]
Energy   intensity   =   Total   energy   of   the   process Sales   revenue 02.294 × 109 KJ/EUR [55]
Specific   liquid   waste   volume   =   Total   liquid   volume   rated   as   waste Mass   of   product 0100%
Reaction   mass   efficiency   =   Mass   of   product Total   mass   of   reagents 100%0%
Total material consumption = Total mass input *2.5 × 10−2 Kg1 Kg
Mass   intensity   =   Total   mass   input Mass   of   product 140 Kg/Kg [56]
Value   mass   intensity   =   Total   mass   input Sales   revenue 052 Kg/EUR [57]
Fractional   water   consumption   =   Volume   of   fresh   water   consumed Mass   of   product 02.95 m3/kg [58]
Water   intensity   =   Volume   of   fresh   water   consumed Sales   revenue 01.55 m3/EUR [58]
Recycled   material   fraction   =   Recycled   mass   input Total   mass   input 10 Kg/Kg
* Total material consumption was calculated considering the mass of a unit of product, equal to 0.025 Kg (in this study) in the best conditions and 40 times that value in the worst condition [56].
Table 3. List of actual values calculated for each sustainability indicator.
Table 3. List of actual values calculated for each sustainability indicator.
IndicatorDescription of the ParameterValueUnit
Global warming potentialTotal mass of CO2 released1.06 × 10−2 Kg
Mass of product2.50 × 10−2 Kg
Ratio43%Kg/Kg
Global warming intensitytotal mass of CO2 released1.06 × 10−2 Kg
sales revenue27.5EUR
Ratio3.9 × 10−4 Kg/EUR
Specific energy intensitytotal energy consumed in the process34.7KJ
mass of product2.50 × 10−2 Kg
Ratio1389.20 KJ/Kg
Energy intensitytotal energy consumed in the process34.7KJ
sales revenue27.5EUR
Ratio1.2629KJ/EUR
Specific liquid waste volumetotal volume of liquid rated as waste (ethanol)6.58 × 10−3Kg
Mass of product2.50 × 10−2Kg
Ratio26%
Reaction mass efficiencyMass of product2.50 × 10−2 Kg
Total mass of reagents3.42 × 10−2Kg
Ratio73%
Total material consumptiontotal mass input3.424 × 10−2 Kg
Mass intensitytotal mass input3.42 × 10−2Kg
mass of product2.50 × 10−2Kg
Ratio1.370 Kg/Kg
Value mass intensityTotal mass input3.42 × 10−2Kg
sales venue27.5EUR
Ratio1.25 × 10−3 Kg/EUR
Fractional water consumptionvolume of fresh water consumed2.50 × 10−2m3
mass of product2.50 × 10−2 Kg
Ratio1.0000 m3/Kg
water intensityvolume of fresh water consumed2.50 × 10−2 m3
sales venue27.5EUR
Ratio9.09 × 10−4 m3/EUR
Recycled material fractionRecycled mass input0Kg
total mass input3.42 × 10−2Kg
Ratio0Kg/Kg
Table 4. Scores calculated before and after optimization of the process.
Table 4. Scores calculated before and after optimization of the process.
Before OptimizationAfter Optimization
Global warming potential57%96%
Global warming intensity100%100%
Specific energy intensity100%100%
Energy intensity100%100%
Specific liquid waste volume74%97%
Reaction mass efficiency73%85%
Total material consumption99%99%
Mass intensity99%99%
Value mass intensity100%100%
Fractional water consumption66%83%
Water intensity100%100%
Recycled material fraction0%45%
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Trucillo, P.; Campardelli, R.; De Marco, I. Environmental and Sustainability Analysis of a Supercritical Carbon Dioxide-Assisted Process for Pharmaceutical Applications. Processes 2021, 9, 1788. https://doi.org/10.3390/pr9101788

AMA Style

Trucillo P, Campardelli R, De Marco I. Environmental and Sustainability Analysis of a Supercritical Carbon Dioxide-Assisted Process for Pharmaceutical Applications. Processes. 2021; 9(10):1788. https://doi.org/10.3390/pr9101788

Chicago/Turabian Style

Trucillo, Paolo, Roberta Campardelli, and Iolanda De Marco. 2021. "Environmental and Sustainability Analysis of a Supercritical Carbon Dioxide-Assisted Process for Pharmaceutical Applications" Processes 9, no. 10: 1788. https://doi.org/10.3390/pr9101788

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop